| Literature DB >> 33790649 |
Haji Aman Deybasso1, Kedir Teji Roba2, Berhanu Nega3, Tefera Belachew1.
Abstract
PURPOSE: Arsi Zone is one of the esophageal cancer endemic areas and is reported to have a high incidence of esophageal cancer in Ethiopia. This study assessed clinicopathological patterns and spatial distributions of esophageal cancer in Arsi Zone, Oromia, Central Ethiopia.Entities:
Keywords: Arsi; Ethiopia; clinical pattern; esophageal cancer; geographical distribution
Year: 2021 PMID: 33790649 PMCID: PMC8001180 DOI: 10.2147/CMAR.S301978
Source DB: PubMed Journal: Cancer Manag Res ISSN: 1179-1322 Impact factor: 3.989
Socio-Demographic Characteristics of EC Patients in Arsi Zone, Oromia, Ethiopia, 2020
| Variables | Sex of the Participants | ||
|---|---|---|---|
| Male | Female | Total | |
| No. (%) | No. (%) | No. (%) | |
| Residence | |||
| Urban | 8 (4.1) | 7 (3.3) | 15 (3.7) |
| Rural | 186 (95.9) | 202 (96.7) | 388 (96.3) |
| Age of the participants | |||
| ≤19 years | 1 (0.5) | 0 (0) | 1 (0.2) |
| 20–29 years | 2 (1.0) | 3 (1.43) | 5 (1.2) |
| 30–39 years | 8 (4.12) | 15 (7.2) | 23 (5.7) |
| 40–49 years | 31 (16.0) | 49 (23.4) | 80 (20.0) |
| 50–59 years | 56 (28.9) | 84 (40.2) | 140 (34.7) |
| 60–69 years | 60 (30.9) | 46 (22) | 106 (26.3) |
| 70–79 years | 30 (15.5) | 9 (4.3) | 39 (9.7) |
| ≥80 years | 6 (3.1) | 3 (1.4) | 9 (2.2) |
Clinico-Pathological Characteristics of Esophageal Cancer Patients in Arsi Zone, Oromia, Ethiopia, 2020
| Variables | Sex of the Participants | Total | |
|---|---|---|---|
| Male | Female | ||
| No. (%) | No. (%) | ||
| Histopathological types | |||
| Squamous cell carcinoma | 191 (98.5) | 205 (98.1) | 396 (98.3) |
| Adenocarcinoma | 4 (1.9) | 3 (1.5) | 7 (1.7) |
| Tumor location | |||
| Cervical | 2 (1) | 0 (0) | 2 (0.5) |
| Upper thorax | 15 (7.7) | 12 (5.7) | 27 (6.7) |
| Mid thorax | 48 (24.7) | 57 (27.3) | 105 (26.1) |
| Lower thorax | 89 (45.9) | 84 (40.2) | 173 (42.9) |
| Gastro Esophageal Junction | 40 (20.6) | 56 (26.8) | 96 (23.8) |
| Degree of tumor differentiation | |||
| Well differentiated | 53 (27.3) | 47 (22.5) | 100 (24.8) |
| Moderately differentiated | 77 (39.7) | 91 (43.5) | 168 (41.7) |
| Poorly differentiated | 44 (22.7) | 44 (21.1) | 88 (21.8) |
| Report not conclusive | 20 (10.3) | 27 (12.9) | 47 (11.7) |
| Presenting symptoms | |||
| Dysphagia and weight loss | 171 (88.1) | 182 (87.1) | 353 (87.6) |
| Vomiting | 23 (11.9) | 27 (12.9) | 50 (12.4) |
| Cancer stage | |||
| Stage 1 | 7 (3.6) | 7 (3.3) | 14 (3.5) |
| Stage 2 | 17 (8.8) | 28 (13.4) | 45 (11.2) |
| Stage 3 | 81 (41.8) | 90 (43.1) | 171 (42.4) |
| Stage 4 | 48 (24.7) | 49 (23.4) | 97 (24.1) |
| Not graded | 41 (21.1) | 35 (16.7) | 76 (18.9) |
Figure 1The number of esophageal cancer patients per district in Arsi Zone, Oromia, Ethiopia, 2020.
Figure 2Map showing the spatial distribution of esophageal cancer cases in Arsi Zone, Oromia, Ethiopia, 2020.